Genfit S.A.

Paris Stock Exchange GNFT.PA

Genfit S.A. Gross Profit Margin for the year ending December 31, 2023: 98.81%

Genfit S.A. Gross Profit Margin is 98.81% for the year ending December 31, 2023, a 0.03% change year over year. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.

Genfit S.A. Gross Profit Margin for the year ending December 31, 2022 was 98.77%, a -1.03% change year over year.
Genfit S.A. Gross Profit Margin for the year ending December 31, 2021 was 99.80%, a 35.61% change year over year.
Genfit S.A. Gross Profit Margin for the year ending December 31, 2020 was 73.59%, a -25.98% change year over year.
Genfit S.A. Gross Profit Margin for the year ending December 31, 2019 was 99.43%, a 103.84% change year over year.

Key data

Date	Gross Profit Margin	Operating Income Margin	EBT Margin	Net Income Margin

Paris Stock Exchange: GNFT.PA

Genfit S.A.

CEO	Mr. M. Pascal Prigent
IPO Date	Dec. 19, 2006
Location	France
Headquarters	Parc EurasantE
Employees	169
Sector	Health Care
Industries Biotechnology Clinical Trials Pharmaceuticals

Description

Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's products include Elafibranor, which is in Phase 3 clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagnosis of nonalcoholic steatohepatitis (NASH) and fibrosis; GNS561, which is in Phase 1b/2 trial to treat patients with cholangiocarcinoma (CCA); and Nitazoxanide, which is in Phase 1 trial to treat acute-on-chronic liver failure. The company has a licensing agreement with Labcorp for the commercialization of NASHnext, a blood-based molecular diagnostic test; and with Genoscience Pharma to develop and commercialize the investigational treatment GNS561 for CCA. Genfit S.A. was incorporated in 1999 and is headquartered in Loos, France.

Key trends

Past 5 years